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The predatory cone snails (Conus) are among the most 
successful living marine animals (~500 living species). 
Each Conus species is a specialist in neuropharmacol­
ogy, and uses venom to capture prey, to escape from 
and defend against predators and possibly to deter 
competitors. An individual cone snail's venom con­
tains a diverse mixture of pharmacological agents, 
mostly small, structurally constrained peptides (cono­
toxins). Individual peptides are selectively targeted to 
a specific isoform of receptor or ion channel. A variety 
of such targets have been identified, including many 
voltage-gated and ligand-gated ion channel subtypes, 
as well as G protein-linked receptors. Although there 
are only a few widely shared structural motifs in 
conotoxins (the majority of the >25,000 peptides in 
these venoms probably belong to only half a dozen 
gene superfamilies), the sequences of peptides are re­
markably divergent from one Conus species to an­
other. We suggest that cone snails undergoing specia- 
tion have, in effect, a mutator phenotype which acts 
specifically on the gene segment encoding the mature 
toxin region. In their 50 million years of evolution, 
cone snails anticipated many features of the modern 
drug industry: disposable hypodermic needles, com­
bination drug therapy, and combinatorial strategies 
for drug discovery. Recent results indicate that the 
Conus peptide system may provide a novel paradigm 
for designing ligands that discriminate between 
closely related members of large families of receptors 
and ion channels. Many Conus peptides may be "Ja- 
nus-ligands," with two distinct recognition faces ori­
ented in different directions, a design which should 
make far greater target specificity possible.
* The E.E. Just Lecture was presented on December 8,1996, in San 
Francisco, California, at the joint meeting of the 6th International 
Congress on Cell Biology and the 36th American Society for Cell 
Biology Annual Meeting.
BIOLOGY OF CONE SNAILS: WHY A 
NEUROPHARMACOLOGICAL STRATEGY?
The carnivorous cone snails (Fig. 1) are relatively 
young in evolutionary terms; the first fossil Conus 
appear only after dinosaurs went extinct (Kohn, 1990). 
However, they comprise what is arguably the largest 
single genus of marine animals living today. All cone 
snails are venomous predators. It is quite likely that 
most Conus use their venoms for multiple purposes, 
including prey capture and defense. All 500 living 
species of cone snails (Kohn, 1976; Rockel et al., 1995) 
have a highly sophisticated venom production appara­
tus and delivery system (Fig. 2). A hallmark of the latter 
is the specialized teeth, which in effect serve both as 
harpoon and disposable hypodermic needle for venom 
delivery (Kohn et al., 1960; Kohn et al., 1972).
Although most Conus move considerably faster than 
would be expected of the proverbial snail, they remain 
relatively slow compared to other ambulatory preda­
tors. Cone snails cannot swim; despite this, a signifi­
cant number have evolved to feed primarily (if not 
exclusively) on fish (Kohn, 1956). For a predator with 
these locomotory disadvantages to specialize in such 
agile prey requires an unusual venom: once the fish- 
hunting snail strikes its prey, extremely rapid and 
effective immobilization usually occurs. Given this 
background biology, it becomes easy to rationalize 
why the major venom components characterized so far 
have been found to target key cell surface-signaling com­
ponents of nervous systems, i.e., ion channels and recep­
tors (Olivera et al., 1985, 1990). Slow-moving or sessile 
venomous predators would have particular need for 
extremely fast-acting venoms, a scenario favoring evolu­
tion of toxins which target nervous systems.
Several features of cone snail venoms have been 
firmly established in recent years. First, the venoms 
are extremely complex—venom from an individual 
Conus may have 50-200 distinct, biologically active 
components. Most of these are small peptides (6-40 
amino acids in length), with the majority being in the 
size range of 12-30 amino acids (see Olivera et al., 
1990). Although Conus toxins are unusually small,
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Figure 1. Ten different cone snails. Shown are the shells of ten Conus species including, top row: the cloth-of-gold cone, Conus textile; the 
cone of the magi, Conus magus. Second row, left to right: the circumcision cone, Conus circumcisus; the geography cone, Conus geographus; 
Dusavel's cone, Conus dusaveli. Third row, left to right: the glory-of-the-sea cone, Conus gloriamaris, the glory-of-India cone, Conus 
milneedwardsi. Bottom row, left to right: the admiral cone, Conus ammiralis; the banded marble cone, Conus bandanus vidua; Hirasei's cone, 
Conus hirasei. The geography cone, C. geographus is responsible for the majority of human fatalities. This species, along with C. magus, C. 
circumcisus, and C. dusaveli, are all likely to be fish hunting. The other Conus shown all hunt other gastropod molluscs, except for C. hirasei, 
which is probably a vermivorous species, although its biology has not been studied.
they are invariably highly constrained conformation­
ally. Most are extensively cross-linked through multi­
ple intramolecular disulfide linkages, although other 
conformation-constraining strategies, such as the pres­
ence of an unusual a-helix-stabilizing posttransla- 
tional modification (McIntosh et al., 1984; Myers et al., 
1990; Olivera et al., 1990) have been discovered.
The complement of peptides found in any one Conus 
venom is strikingly different from that found in the 
venom of any other Conus species. Thus, in the whole 
genus, many tens of thousands of distinct pharmaco­
logically active peptides have been evolved. A ques­
tion which immediately arises is why individual cone
snails should need so many different peptides. We 
speculate that the complement of peptides in a venom 
may be used for at least three general purposes. An 
individual peptide may play a role in 1) prey capture, 
directly or indirectly; 2) defense and escape from 
predators; or 3) other biological phenomena (such as 
interaction with potential competitors, for example).
CONE SNAILS CAPTURE PREY USING A 
COMBINATION DRUG STRATEGY
Although each of the 500 different cone snail species is 
usually highly specialized with respect to prey, the
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Figure 2. The venom apparatus and harpoon-like tooth of Conus 
purpurascens. Upper panel, a representation of the venom apparatus 
of C. purpurascens. The venom apparatus in all cone snails com­
prises: vb, a venom bulb which pushes the venom out; vd, the 
venom duct where the venom is actually made and stored; rs, a 
radula sac where the harpoon-like teeth are stored; h, harpoon-like 
teeth; p, pharynx; pr, proboscis, which is used to deliver the har­
poon and venom to the prey. The radula sac has been shown in 
cross-section, to make the harpoons visible. Each harpoon is used 
only once; in the radula sac they are found in various stages of 
assembly. Lower panel, a close-up electron micrograph of a single 
harpoon-like tooth. Venom is ejected through the tooth.
genus as a whole envenomates a surprisingly broad 
range of prey types. The largest group of Conus (>150 
species) probably hunt various polychaete worms. 
However, a substantial number (ca. 70) prey on fish 
and another ~70 specialize on molluscs. In addition, a 
number of Conus species feed on hemichordates and 
echiuroids. By far the best understood in terms of 
molecular mechanisms are the fish-hunting cone 
snails.
Fish-hunting cone snails can generally be divided 
into two broad classes: "hook-and-line" fishing snails, 
which use their long probosces to harpoon prey with 
a disposable harpoon-like tooth (which also serves as 
a hypodermic needle) and "net-fishing" cone snails, 
which engulf prey with a large distensible mouth 
before stinging (Fig. 3). Among the latter is the geog­
raphy cone, Conus geographus, the species most lethal 
to man—70% of untreated hum an stinging cases are 
fatal (Cruz and White, 1995). Although a hook-and-
line strategy would permit prey capture at a greater 
distance, the potential advantage of net fishing is that 
it becomes possible to bag a whole school of smaller 
fish at one time.
For Conus purpurascens, which uses a hook-and- 
line strategy to capture fish, the injected venom has 
been shown to sequentially elicit two distinct immo­
bilization phases, excitotoxic shock followed by 
neurom uscular block (Terlau et al., 1996). In effect, 
one group of peptides hyperexcites targeted electri­
cally excitable cells around the venom injection site, 
whereas a second group of peptide toxins sup­
presses the m otor circuitry of the prey. The first 
physiological effect, excitotoxic shock, requires the 
combined action of a peptide which prevents volt­
age-gated sodium  channels from closing once they 
have opened, thereby increasing the influx of so­
dium  (Shon et al., 1995) and a second toxin which 
blocks certain subtypes of potassium  channels, 
thereby inhibiting potassium  efflux (Terlau et al., 
1996). The combination of increased sodium influx 
and decreased potassium  efflux results in the m as­
sive depolarization of neuronal circuitry at the in­
jection site. This has the effect of stunning the fish 
almost instantaneously upon venom injection.
A second, nonoverlapping, group of toxins in the 
same venom consists of peptides that act synergis- 
tically to block neurom uscular transmission. All 
fish-hunting Conus have a subset of such toxins, 
which typically include 1) a group of peptides 
which antagonize different subtypes of presynaptic 
voltage-gated calcium channels (Olivera et al., 1994) 
and thereby inhibit neurotransm itter release; 2) 
competitive and noncompetitive antagonists of the 
postsynaptic nicotinic acetylcholine receptor (Gray 
et al., 1984; Shon et al., 1997a) that prevent depolar­
ization at the muscle end plate; and 3) skeletal m us­
cle voltage-gated sodium  channel blockers which 
act like tetrodotoxin (Spence et al., 1977; Stone and 
Gray, 1982; Nakam ura et al., 1983; Sato et al., 1983; 
Cruz et al., 1985); these directly abolish muscle ac­
tion potentials. Most piscivorous Conus have three 
or four different major peptides which, by acting 
together, very efficiently wipe out the m otor cir­
cuitry of the fish prey. The concerted action of this 
second group is shown in Fig. 4.
The first group of toxins act at the venom injection 
site to stun prey. Thus, the fish is immobilized during 
the lag time required for the second group of toxins to 
reach their targets in the neuromuscular system. By 
having both groups of toxins, the snail maximizes the 
probability that the fish will be continuously immobi­
lized after it has been stung, thereby increasing the 
likelihood that prey will be captured. Both general 
physiological strategies (stunning the fish by excito- 
toxic shock, paralysis by neuromuscular block) re­
quire the synergistic action of multiple peptides. We
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Figure 3. A cartoon representing the hook-and-line (top panel) and the net strategy (bottom panel) of fish-hunting cone snails. Conus 
striatus, magus, and purpurascens are examples of hook-and-line piscivores. Species such as Conus tulipa and Conus geographus use a net 
strategy.
refer to such functionally linked groups of peptides 
acting together as "toxin cabals." The toxins which 
cause excitotoxic shock together comprise the "light­
ning-strike cabal" while those causing neuromuscular 
block are designated the "motor cabal."
A modern development in pharmacology which has 
attracted considerable attention is the use of combina­
tion drug therapy, particularly for more intractable 
health problems such as AIDS or incurable tumors. 
The cone snails appear to have anticipated the devel­
opment of pharmacological combination strategies by 
over 40 million years. The peptides which contribute 
to excitotoxic shock (the lightning-strike cabal) as well 
as the peptides that disrupt neuromuscular transmis­
sion (the motor cabal) comprise, in effect, a highly 
sophisticated application of a combination drug strat­
egy in a natural system. (Since the relevant "drugs" 
are hardly beneficial to the prey, it seems inappropri­
ate to refer to this as combination drug "therapy").
In addition to the two toxin cabals directly involved 
in prey immobilization, other venom peptides may 
play accessory roles to enhance the probability of prey 
capture. For example, there is evidence for peptides 
that suppress the fight-or-flight response of the fish 
prey (Cartier et al., 1996; Tavazoie et al., 1997). In 
addition, vasopressin-like peptides which constrict ar­
teries may promote more rapid uptake of paralytic 
peptides of the motor cabal by the capillary bed (Cruz 
et al., 1987). The impression created by the pharmaco­
logical characterization carried out so far is of an
extremely strong selection pressure for very rapid 
prey immobilization and a biological system able to 
mount a sophisticated response in evolutionary time 
to address this pressure.
GENERATING NEUROPHARMACOLOGICAL 
DIVERSITY THROUGH A COMBINATORIAL 
LIBRARY SEARCH STRATEGY
As more Conus peptides have been analyzed, it has 
become apparent that the venoms from different spe­
cies have peptides surprisingly divergent in sequence 
from each other. Very rapid evolution of novel venom 
components has apparently occurred during the radi­
ation of these molluscs in the last ~50 million years. 
As a result, homologous peptides from different spe­
cies often have diverged to the point of making any 
sequence similarity unrecognizable. This is illustrated 
by the structurally diverse peptides shown in Fig. 5, 
all of which inhibit the postsynaptic nicotinic acetyl­
choline receptor at the neuromuscular junction.
Although the molecular mechanisms that lead to 
rapid interspecific divergence are not understood, the 
phenomenon has become better defined. Conus pep­
tides are initially translated as larger prepropeptide 
precursors; a mature Conus peptide of 20 amino acids 
is generally processed from a 70 to 80 amino acid 
precursor, with a single nonrepeated copy of the toxin 
encoded at the C-terminal end (Woodward et al., 1990; 
Colledge et al., 1992). Peptide diversification appar­
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Figure 4. Mechanism of blocking neuromuscular transmission. 
The "motor cabal" of toxins (see text) targets multiple components 
in the neuromuscular circuit (top panel). Three different toxins (w-, 
a- and -^conotoxins) act on three different target components: 1) 
presynaptic Ca2+ channels; 2) nicotinic acetylcholine receptors; and 
3) voltage-gated skeletal muscle Na+ channels. Bottom panel, syn­
ergy in Conus venoms is achieved both by inhibiting multiple com­
ponents as well as multiple sites in a single macromolecular com­
ponent. Two unrelated toxins (a- and ^-conotoxins) inhibit one 
receptor, the postsynaptic nicotinic acetylcholine receptor at differ­
ent sites.
ently arises by focal hypermutation of the C-terminal 
toxin-encoding region while the rest of the precursor 
sequence remains largely conserved. The most con­
served sequence feature of all is the signal sequence 
(Fig. 6).
In many ways, the pattern of conserved and variable 
regions in Conus peptide precursors is opposite that of 
conventional secreted polypeptides. Two Conus pep­
tide precursors, w-conotoxins M viia and Gvia (Ol­
ivera et al., 1984,1987) from two different fish-hunting 
cone snails, are compared in Fig. 6. These two w- 
conotoxins target precisely the same site on an a 1B
n ---------1 I
a - G I  ECCNPACGRHY SC #
n ----------- 1 I
a - E I  RDOCCYHPTCNMSNPQIC#
I n ---------1 I I
a - S I I  GCCCNPACGPNYGCGTSCS^
11 i n  i
a A -P IV A  GCCGSYONAACHOCSCKDROSYCGQ#
n ----------- ;--------------1 I I
V |/ - P I I I E  HOOCCLYGKCRRYOGCSSASCCQR#
Figure 5. Diverse structures of peptides from different cone snails 
which inhibit the nicotinic acetylcholine receptor at the postsynaptic 
terminus of the neuromuscular junction. The first four compounds 
[a-Gi (Gray et al., 1981); a-Ei (Martinez et al., 1995); a-Sii (Ramilo et 
al., 1992); aA-PiVA (Hopkins et al., 1995)] are all competitive antag­
onists of the receptor. The fifth peptide, ^-piiie (Shon et al., 1997a) 
acts at a different site on the receptor complex and is a noncompet­
itive antagonist. Note the lack of sequence similarity between all of 
these peptides which are all produced in the venom ducts of fish- 
hunting Conus species. ~, free C-terminus; #, amidated e-terminus; 
O, hydroxyproline.
subunit of a voltage-gated calcium channel. Total se­
quence conservation might have been predicted for 
two such peptides that both target the same site and 
are found in species in the same genus. In contrast, we 
would not, a priori, expect signal sequence conserva­
tion (in most secreted proteins, the N-terminal signal 
region is the least conserved sequence element). The 
reality (Fig. 6) is the converse of these expectations: the 
signal sequence region is completely conserved, but 
the mature toxins show extreme divergence in se­
quence (^30% of noncysteine amino acids conserved). 
This juxtaposition of conserved and hypervariable re­
gions within the same translation product is reminis­
cent of antibody-encoding genes in the mammalian 
immune system, where special genetic mechanisms 
have evolved to generate diversity.
In the midst of the C-terminal toxin region which is 
generally hypervariable, the cysteine residues in­
volved in the disulfide framework of the mature toxin 
are totally conserved. It is noteworthy that many cono­
toxin N-terminal signal sequences contain one or two 
cysteine residues (for example, those shown in Fig. 6), 
whereas the longer intervening propeptide region (be­
tween signal sequence and C-terminal mature toxin 
peptide) never has any Cys residues. The extremely 
conserved signal sequence may be optimally designed 
to target the precursor to a specific region in the en­
doplasmic reticulum; this may be important for spe­
cific posttranslational modifications as well as sorting 
into specialized secretory vesicles. In addition, how-
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Signal Sequence
Non-identities % Divergence 
0/22 0
Pro Region
Non-identities % Divergence 
3/23 13
Toxin
Non-identities % Divergence 
Cys 0/6 0
Non-Cys 16/22 73
Figure 6. A comparison of the precursor sequences of two w-conotoxins, Gvia (top sequence) and Mviia (bottom sequence) from Conus 
geographus and Conus magus, respectively. Both of these toxins block the N-type voltage-gated calcium channel and compete with each other 
for binding. The entire precursor sequence is shown. The red amino acids comprise the signal sequence, whereas the solid arrow indicates 
the proteolytic site which generates the mature toxin. The mature toxin region is shown in capital letters, and the cysteine residues involved 
in disulfide bonding are shown bold. All loci where the two sequences differ are indicated by asterisks. It is notable that although the signal 
sequences are entirely identical, the vast majority of the non-Cys amino acids of mature w-conotoxin Gvia are different from the 
corresponding w-conotoxin Mviia residues; in contrast, the Cys residues in this region are completely conserved.
ever, the presence of Cys residues in many signal 
sequences suggests that signal sequences may also 
play a sequestration role, i.e., to avoid premature or 
inappropriate disulfide bond formation in the mature 
toxin region. The latter hypothesis predicts that a mu­
tation either in a Cys residue in the mature toxin 
region or in the signal sequence may perturb proper 
processing and secretion. Such mutations would be 
selected against at the cellular processing level, result­
ing in a coconservation of N-terminal signal sequences 
and Cys residues in the C-terminal toxin region. Thus, 
rapid toxin evolution may occur via a pathway in 
which conservation of structural frameworks based on 
Cys residues is selected for, even at the level of cellular 
processing of precursors.
Rapid hypermutation of venom peptides could be 
an optimum evolutionary strategy when prey, preda­
tors, and competitors change very rapidly (due to a 
sudden climate change or geological catastrophe, for 
example). Special mechanisms may have evolved that 
accelerate the generation of new venom peptides—in 
effect, by hypermutating the variable sequences be­
tween disulfide frameworks, cone snails employ a 
combinatorial library search strategy to evolve new 
peptides in their venoms.
Although hypermutation of peptide sequences is 
undoubtedly the main engine for generating peptide 
diversity in Conus, an unprecedented series of post- 
translational modifications provide an overlying level 
of diversity (Jimenez et al., 1997). Some of these mod­
ifications (such as epimerization of L-tryptophan to 
D-tryptophan and posttranslational bromination of 
Trp to 6-Br-tryptophan) have not been described pre­
viously outside the Conus peptide system. Others (i.e., 
y-carboxylation of glutamate to y-carboxyglutamate)
were described previously only in specialized, phylo- 
genetically distant systems. One recently character­
ized small Conus peptide may be the most intensively 
posttranslationally modified polypeptide known: six 
posttranslational modifications occur in the mature 
toxin region to generate the final functional gene prod­
uct of only eight amino acids (Jimenez et al., 1997). In 
some cases, posttranslational modification occurs to 
constrain Conus peptide conformation. For example, 
the posttranslational y-carboxylation of glutamate res­
idues (McIntosh et al., 1984) strongly promotes forma­
tion of an a-helix in at least some Conus peptides 
(Myers et al., 1990).
EVOLVING HIGHLY REFINED TARGETING
One important trend in modern drug development is 
to refine drug target specificity. Particularly for phar­
macological agents that need to be applied chroni­
cally, severe side effects are a continuing problem. A 
current research imperative is to develop "clean 
drugs" that only target the therapeutically relevant 
molecule and not other closely related subtypes. In 
this respect, cone snails excel greatly compared to 
what the drug industry can produce at the present 
time. The Conus peptide system may help to reveal 
molecular recognition principles that underlie highly 
refined targeting.
In almost every case that has been carefully exam­
ined, Conus peptides appear to be much more selective 
than other ligands targeting the same receptor. Thus, 
the major paralytic a-conotoxin series in fish-hunting 
cone snail venoms (such as a-conotoxin Gi shown in 
Fig. 5) discriminate between the two ligand-binding 
sites on the nicotinic acetylcholine receptor by three to
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four orders of magnitude; in contrast, analogous snake 
toxins such as a-bungarotoxin have affinities that dif­
fer little for the two ligand-binding sites. Additionally, 
the snake toxins target certain neuronal nicotinic re­
ceptors (belonging to the a7 subtype)—these are not 
targeted at all by the a-conotoxins. Thus, this group of 
a-conotoxins may be the most specifically targeted 
nicotinic antagonists known. Another example of ex­
ceptionally selective targeting are the ^-conotoxins, 
which exhibit much more specificity for particular 
sodium channel subtypes (i.e., those of skeletal mus­
cle) than do the classical guanidinium toxins, tetrodo- 
toxin and saxitoxin.
Why are Conus peptides exceptionally selective for 
their receptor targets? Two reasons are suggested by 
cone snail biology. The necessity for very rapid prey 
immobilization would provide strong selection pres­
sure for ligands not to bind physiologically irrelevant 
targets. Binding to other molecules with KDs <  0.1 ^M 
could mean multiple rounds of association and disso­
ciation en route to the true physiological receptors. 
This would cause a lag before the peptide could elicit 
its biological effect. In addition, increasing venom 
complexity raises the probability that two peptides in 
the same venom would jam each other's function 
physiologically, a possibility greatly diminished if 
venom peptides were narrowly targeted. In the work 
on C. purpurascens venom described above (Terlau et 
al., 1996), one peptide increases total inflow of sodium 
through voltage-gated sodium channels (part of the 
lightning strike cabal), where another peptide blocks 
conductance through sodium channels (part of the 
motor cabal). Clearly, the two peptides would act at 
cross purposes if they were to act on sodium channels 
of the same cells. In fact, each peptide is targeted with 
great specificity to different molecular forms of volt­
age-gated sodium channels located in distinct popu­
lations of cells. Consequently, in vivo, no functional 
interference occurs between these two potentially an­
tagonistic venom components.
The specificity of Conus toxins can be very impres­
sive indeed. In the case of voltage-gated Ca2+ channel- 
targeted toxins (such as w-conotoxins Gvia or Mviia) 
discrimination between various calcium channel sub­
types can be >106-fold (Olivera et al., 1994). The ability 
to discriminate between closely related members of 
the calcium channel family is being exploited medi­
cally to develop one Conus peptide, w-conotoxin 
M viia as a drug for the alleviation of intractable pain. 
Within the spinal cord, the targeted a1B-containing 
voltage-gated calcium channel complexes are largely 
restricted to sensory regions. The high degree of target 
discrimination exhibited by this peptide has made it a 
feasible candidate for drug development; it is now in 
advanced clinical trials (Bowersox et al., 1997). In ad­
dition, a class of subtype-specific N-methyl-D-aspar- 
tate receptor antagonists, the conantokins, exhibit
unique properties that give them considerable poten­
tial for development as anticonvulsant drugs (White et 
al., 1997).
A major question which needs to be investigated 
further are the mechanisms by which Conus peptides 
discriminate among target subtypes. Recently, evi­
dence obtained by my colleagues J. Michael McIntosh, 
G. Edward Cartier, and Doju Yoshikami on a cono­
toxin whose structure was solved by Shon et al. 
(1997b) suggests a "dock-and-lock" recognition mech­
anism. The very high subtype selectivity of this Conus 
peptide appears to arise from the presence of two 
distinct interaction faces, called the "docking" and the 
"locking" faces, which in turn interact with comple­
mentary docking and locking sites on the target recep­
tor. The experimental results are consistent with initial 
contact being made by the docking face on the peptide 
interacting with a docking site on the receptor; this 
then facilitates formation of functionally significant 
locking interactions of the toxin locking face with the 
receptor locking site.
We have coined the term "Janus-ligand" when, as in 
the example above, two interaction faces are present 
that are oriented in different directions (after Janus, 
the two-faced Roman god of beginnings). This could 
provide a basis for much more refined discrimination 
between homologous members of a large receptor or 
ion channel family. We suggest that many Conus pep­
tides may be similarly two-faced Janus-ligands that 
use a strategically different molecular recognition par­
adigm from "normal" ligands. Other novel design 
strategies for subtype discrimination may well have 
evolved in these venoms.
CONE SNAIL PEPTIDES: AN HISTORICAL 
VIEW
A plausible scenario can be constructed for how cone 
snails may have evolved their complex venoms over 
the last 50 million years. Once the first venom able to 
cause prey paralysis by targeting a key component of 
the nervous system had evolved, a gradual expansion 
of the pharmacopoeia to yield more and more effective 
venom for prey immobilization may have taken place 
(this could well have occurred in taxa ancestral to 
Conus). Additionally, any venom components that 
could be used defensively would confer a strong se­
lective advantage. As the venoms of Conus species 
slowly assumed greater complexity with time, these 
would then be subject to more selective variables.
With increasing venom complexity, a successive se­
ries of sudden changes in the environment would be 
expected to provide a correspondingly greater advan­
tage to species that could mutate their venoms rela­
tively quickly to adapt to a new ecological context, 
providing a "first-out-of-the-gate" evolutionary ad­
vantage. This is quite analogous to the observation
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(LeClerc et al., 1996) that pathological microorganisms 
that have recently colonized new hosts have a much 
higher frequency of the m ut phenotype, which confers 
a greatly increased frequency of mutation. Further­
more, when successive rounds of strong selection are 
applied in vitro, an entire bacterial population is 
found with the hypermutagenic m ut phenotype (Mao 
et al., 1997). We suggest that successive extreme 
changes in climate an d /o r geological catastrophes 
may similarly select for hypermutation phenotypes in 
macroorganisms, with Conus peptides being an ex­
treme example. The ability of cone snails to rapidly 
evolve a new complement of peptides after a geolog­
ical catastrophe may be the key factor in the species 
richness of the genus Conus at the present time.
Our historical reconstruction predicts that for the 
last 50 million years peptides selected for one set of 
prey or predators may have had to be successively 
(and rapidly, in a geological time scale) mutagenized, 
thus generating a new set of peptides optimized to a 
different ecological context. However, receptors and 
ion channels in different nervous systems are quite 
conserved. Thus, a ligand for a nicotinic receptor tar­
geted to emerging new prey would most likely be 
derived by mutagenesis from a gene encoding a li­
gand for nicotinic receptors in the original biological 
context, to take a specific example. Thus, a nicotinic 
receptor antagonist in a present-day cone snail venom 
may, in the course of its geological history, have un­
dergone multiple rounds of selection for optimally 
targeting nicotinic receptors in different animals and 
even for different nicotinic receptor subtypes.
Thus, over tens of millions of years, the ligands 
present in Conus venoms may, in effect, have been 
subject to multiple rounds of selection against a target 
receptor family. Janus-ligands may be one conse­
quence of such reiterative selection over evolutionary 
time. Much of the molecular diversity in all nervous 
systems stems from assembling macromolecular com­
plexes in a modular and combinatorial fashion. Het- 
eromeric complexes are characteristic of both ligand- 
gated ion channels (such as the nicotinic receptor) or 
voltage-gated channels (such as K+ channels) with 
subunit interfaces of the type a x p y  where ax and 3y 
may represent members of two different gene families 
with many homologues (a1, a2, a3 . . .  etc., and /31, /32, 
133, etc.). The functional receptor or ion channel com­
plex is typically a tetrameric or pentameric combina­
tion of specific a  and 3  subunits. Ordinary ligands 
would generally target any receptor complex which 
contained a high-affinity subunit target (such as a x). 
Janus-ligands with two different interaction faces 
would be one structural design adaptation that would 
be favored by reiterative rounds of selection for tar­
gets with a modular organization. Because a Janus- 
ligand has two distinct recognition interfaces, it would 
have much higher specificity (i.e., of the ax-containing
complexes, only those specifically containing adjacent 
a x p y  subunits would be high affinity targets); this 
would pick out a specific target isoform from many 
closely related ones in a large family of heteromeric 
receptors or ion channels. There is much that remains 
to be understood about the venom system and indi­
vidual venom peptides observed in cone snails today; 
it seems wise to keep in mind that these are the end 
result of the historical forces described above.
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